Fundz

SEN-JAM PHARMACEUTICAL LLC

Lloyd Harbor, New York, United States · Healthcare

Sen-Jam Pharmaceutical is on a mission to help people live side-effect free. We develop consumer healthcare products that help people stay strong by mitigating common side effects from medicines and everyday living. Sen-Jam's Global scientists have developed a multi-indication patent and FDA-pending product for the prevention of pain and flu-like symptoms for indications not currently being add

Key facts

Headquarters
Lloyd Harbor, New York, United States
Employees
Unknown
Industries
Healthcare
Status
Private
Website
sen-jam.com
LinkedIn
Company page

Recent activity at SEN-JAM PHARMACEUTICAL LLC

Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.

SEN-JAM PHARMACEUTICAL LLC funding history

DateRoundAmount
Apr 2023Series A$295K
Oct 2022Series AUndisclosed
Jul 2022Funding RoundUndisclosed
Feb 2020VentureUndisclosed

Leadership

  • James Iversen, Executive Officer, Promoter

Verified email and direct lines for SEN-JAM PHARMACEUTICAL LLC’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.

Companies similar to SEN-JAM PHARMACEUTICAL LLC

About SEN-JAM PHARMACEUTICAL LLC: questions and answers

What does SEN-JAM PHARMACEUTICAL LLC do?

Sen-Jam Pharmaceutical is on a mission to help people live side-effect free. We develop consumer healthcare products that help people stay strong by mitigating common side effects from medicines and everyday living. Sen-Jam's Global scientists have developed a multi-indication patent and FDA-pending product for the prevention of pain and flu-like symptoms for indications not currently being add

Where is SEN-JAM PHARMACEUTICAL LLC headquartered?

SEN-JAM PHARMACEUTICAL LLC is headquartered in Lloyd Harbor, New York, United States.

Has SEN-JAM PHARMACEUTICAL LLC raised funding?

Yes. Fundz has recorded 4 funding events for SEN-JAM PHARMACEUTICAL LLC. The most recent, Series A of $295K, was in Apr 2023.

What is the latest news on SEN-JAM PHARMACEUTICAL LLC?

On Feb 10, 2025, Sen-Jam Pharmaceutical Announces Strategic Collaboration with Destum Partners for Licensing Opportunities on SJP-001 and SJP-002C.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches SEN-JAM PHARMACEUTICAL LLC across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.